Meiji Holdings Co., Ltd. (TYO:2269)
Japan · Delayed Price · Currency is JPY | Market Cap | 1.17T +44.8% |
| Revenue (ttm) | 1.19T +3.5% |
| Net Income | 40.25B -14.3% |
| EPS | 148.49 -14.2% |
| Shares Out | 271.10M |
| PE Ratio | 29.07 |
| Forward PE | 17.49 |
| Dividend | 110.00 (2.55%) |
| Ex-Dividend Date | Sep 29, 2026 |
| Volume | 628,600 |
| Open | 4,280.00 |
| Previous Close | 4,317.00 |
| Day's Range | 4,280.00 - 4,350.00 |
| 52-Week Range | 2,945.00 - 4,608.00 |
| Beta | 0.18 |
| Analysts | Buy |
| Price Target | 4,660.00 (+8.1%) |
| Earnings Date | Nov 12, 2026 |
About Meiji Holdings
Meiji Holdings Co., Ltd., together with its subsidiaries, manufactures and sells food products and pharmaceuticals in Japan, China, Asia, North America, Europe, and internationally. It operates in two segments, Food and Pharmaceuticals. The company offers milk, yogurt, cheese, ice cream, chocolate, gummy candy, protein, nutrition for infants and children, beauty supplements, and nutritional products. It also provides drugs for infectious diseases and central nervous system disorders, as well as vaccines, blood plasma products, generic drugs, an... [Read more]
Financial Performance
In fiscal year 2026, Meiji Holdings's revenue was 1.17 trillion, an increase of 1.70% compared to the previous year's 1.15 trillion. Earnings were 35.08 billion, a decrease of -30.95%.
Financial StatementsAnalyst Summary
According to 10 analysts, the average rating for 2269 stock is "Buy." The 12-month stock price target is ¥4,660, which is an increase of 8.10% from the latest price.
News
Meiji Holdings Quarterly report: Q1 2027
Meiji Holdings has published its Q1 2027 quarterly earnings report on August 5, 2026.
Meiji Holdings Slides: Q1 2027
Meiji Holdings has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on August 5, 2026.
Meiji Holdings Earnings Call Transcript: Q4 2026
Operating profit exceeded plan in FY 2025, driven by pharmaceuticals, while food segment lagged due to cost pressures and China impairment. FY 2026 targets higher profit and ROE recovery, with structural reforms and growth in key products and overseas markets.
Meiji Holdings Quarterly report: Q4 2026
Meiji Holdings has published its Q4 2026 quarterly earnings report on May 14, 2026.
Meiji Holdings Slides: Q4 2026
Meiji Holdings has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 14, 2026.
Meiji Holdings Slides: Investor presentation
Meiji Holdings has posted slides in relation to its latest quarterly earnings report, which was published on March 25, 2026.
Meiji Holdings Quarterly report: Q3 2026
Meiji Holdings has published its Q3 2026 quarterly earnings report on February 12, 2026.
Meiji Holdings Slides: Q3 2026
Meiji Holdings has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 12, 2026.
Meiji Holdings Earnings Call Transcript: Q2 2026
First half operating profit exceeded plan despite lower net sales and profit year-on-year, with strong pharmaceuticals and resilient food segments. Full-year sales guidance was revised down, but profit forecasts remain unchanged amid ongoing structural reforms and cost pressures.
Meiji Holdings Quarterly report: Q2 2026
Meiji Holdings has published its Q2 2026 quarterly earnings report on November 13, 2025.
Meiji Holdings Slides: Q2 2026
Meiji Holdings has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 13, 2025.